相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma
D. J. Pinato et al.
BRITISH JOURNAL OF CANCER (2013)
Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells
S. Singh et al.
CELL DEATH AND DIFFERENTIATION (2013)
PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity Is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer
Amanda Herzog et al.
CLINICAL CANCER RESEARCH (2013)
Molecular Pathways: Targeting Mechanisms of Asbestos and Erionite Carcinogenesis in Mesothelioma
Michele Carbone et al.
CLINICAL CANCER RESEARCH (2012)
Group I p21-Activated Kinases (PAKs) Promote Tumor Cell Proliferation and Survival through the AKT1 and Raf-MAPK Pathways
Craig W. Menges et al.
MOLECULAR CANCER RESEARCH (2012)
Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)
S. Cedres et al.
LUNG CANCER (2012)
Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy
Bruno Fischer et al.
LUNG CANCER (2012)
Perifosine as a Potential Novel Anti-Cancer Agent Inhibits EGFR/MET-AKT Axis in Malignant Pleural Mesothelioma
Giulia Pinton et al.
PLOS ONE (2012)
Activation of the Phosphoinositide-3-Kinase and Mammalian Target of Rapamycin Signaling Pathways Are Associated With Shortened Survival in Patients With Malignant Peritoneal Mesothelioma
Sheelu Varghese et al.
CANCER (2011)
ERK2 is essential for the growth of human epithelioid malignant mesotheliomas
Arti Shukla et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Coactivation of Receptor Tyrosine Kinases in Malignant Mesothelioma as a Rationale for Combination Targeted Therapy
Marie Brevet et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
AXL regulates mesothelioma proliferation and invasiveness
W-B Ou et al.
ONCOGENE (2011)
mTOR Kinase Inhibition Causes Feedback-Dependent Biphasic Regulation of AKT Signaling
Vanessa S. Rodrik-Outmezguine et al.
CANCER DISCOVERY (2011)
Targeted Inhibition of Multiple Receptor Tyrosine Kinases in Mesothelioma
Wen-Bin Ou et al.
NEOPLASIA (2011)
Activation of Murine Double Minute 2 by Akt in Mammary Epithelium Delays Mammary Involution and Accelerates Mammary Tumorigenesis
Xiaoyun Cheng et al.
CANCER RESEARCH (2010)
Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma
Federica Perrone et al.
EUROPEAN JOURNAL OF CANCER (2010)
Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma
B. A. Jacobson et al.
BRITISH JOURNAL OF CANCER (2009)
Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells
Koji Kawaguchi et al.
CARCINOGENESIS (2009)
Inhibition of Hsp90 Leads to Cell Cycle Arrest and Apoptosis in Human Malignant Pleural Mesothelioma
Junichi Okamoto et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Ras pathway activation in malignant mesothelioma
Manish R. Patel et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma
R Jagadeeswaran et al.
CANCER RESEARCH (2006)
Inhibition of the met receptor in mesothelioma
T Mukohara et al.
CLINICAL CANCER RESEARCH (2005)
Limited efficacy of imatinib mesylate in malignant mesothelioma: A phase II trial
A Mathy et al.
LUNG CANCER (2005)
Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth
DA Altomare et al.
ONCOGENE (2005)
Up-regulation of EphB4 in mesothelioma and its biological significance
GB Xia et al.
CLINICAL CANCER RESEARCH (2005)
Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling
GJ Gordon et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Gefitinib in patients with malignant mesothelioma: A phase II study by the cancer and leukemia group B
R Govindan et al.
CLINICAL CANCER RESEARCH (2005)
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
HG Wendel et al.
NATURE (2004)
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
PK Majumder et al.
NATURE MEDICINE (2004)
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
BHP Zhou et al.
NATURE CELL BIOLOGY (2001)
Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases
P Harvey et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
